...
首页> 外文期刊>International Seminars in Surgical Oncology >A long-term survivor of repeated inguinal nodes recurrence of papillary serous adenocarcinoma of CUP: case report
【24h】

A long-term survivor of repeated inguinal nodes recurrence of papillary serous adenocarcinoma of CUP: case report

机译:CUP乳头状浆液性腺癌反复腹股沟淋巴结复发的长期幸存者:病例报告

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Tumor spread beyond the peritoneal cavity in cases of papillary serous adenocarcinoma of the unknown primary (CUP) is a rare late event and carries a poor prognosis. Case presentation A 71-year-old female was referred to our hospital because of a large right inguinal tumor with biopsy evidence of carcinoma as well as an elevated serum CA125 (cancer antigen 125). She underwent complete resection of the right inguinal tumor and multiple pelvic tumors, which involved the rectum, ovary and uterus. Pathological examination revealed the tumors to be metastases of a papillary serous adenocarcinoma with a psammoma body of CUP. On the 28th postoperative day, newly developed asymptomatic small left inguinal node metastases in the setting of a normal CA125 level were removed. Four and a half years after the primary resection, the CA125 level increased again and newly developed asymptomatic metastases were found in the right deep inguinal nodes and extirpated at that time. All surgical resections followed the modified FAM (5FU, Adriamycin; ADM, MMC) regimen, including protracted dairy oral administration of UFT or 5'-FDUR, Cimetidine and PSK (protein-bound polysaccharide K) as an immunomodulator or biological response modifier in conjunction with intermittent one-day continuous infusion (ADM+MMC) or intermittent single bolus injection of ADM+MMC. At present, the patient has been living in good health for almost 7 years with no evidence of relapse. Conclusion Aggressive resection surgery followed by effective adjuvant chemotherapy is necessary for surviving long time without relapse of poorly prognostic patients with metastases outside of the abdominal cavity from peritoneal papillary serous adenocarcinomas.
机译:背景未知原发性乳头状浆液性腺癌(CUP)病例中,肿瘤扩散到腹膜腔以外是罕见的晚期事件,预后较差。病例介绍一名71岁的女性因巨大的右腹股沟腹腔肿瘤(具有活检的证据)以及血清CA125(癌症抗原125)升高而被转诊至我院。她对右侧腹股沟肿瘤和多处盆腔肿瘤进行了完全切除,这些肿瘤累及直肠,卵巢和子宫。病理检查发现,该肿瘤为乳头状浆液性腺癌的转移,伴有银屑病的淋巴瘤。术后第28天,在正常CA125水平下清除了新发展的无症状小左腹股沟淋巴结转移。初次切除术后四年半,CA125水平再次升高,并在右侧腹股沟深处发现新发展的无症状转移灶,并在那时将其切除。所有手术切除均遵循改良的FAM(5FU,阿霉素; ADM,MMC)方案,包括延长乳制品口服给予UFT或5'-FDUR,西咪替丁和PSK(结合蛋白的多糖K)作为免疫调节剂或生物反应调节剂,间歇性一日连续输注(ADM + MMC)或间歇性单次推注ADM + MMC。目前,该患者已经健康好了近7年,没有复发的迹象。结论积极切除手术后再行有效的辅助化疗对于长期生存且不复发的腹膜外乳头状浆液性腺癌腹腔外转移患者是必要的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号